Based on the knowledge that the mucosal immune system and its predominant effector, secretory IgA, forms the first line of defense at the interface between the pulmonary epithelial surface an the external environment and that resistance to respiratory viral infections correlates with the presence of viral specific IgA antibodies in the mucosal secretions, this proposal seeks to determine the mechanism(s) by which secretory IgA neutralizes virus at the mucosal surface. This project will employ a model system of a natural respiratory pathogen of mice, Sendai virus, a member of the parainfluenza group. A series of anti-Sendai IgA monoclonal antibodies has been generated, and characterized for antigenic specificity and in vitro biologic activities. These anti- viral IgA monoclonal antibodies will be used in three major kinds of studies. First, passive immunization studies have been designed to determine and compare the protection afforded by locally versus systemically administered antibody of IgA and other isotypes against subsequent viral challenge. Second, radiolabeled monoclonal antibodies will be used to examine the transport kinetics of serum dimeric and monomeric IgA as compared to IgG into the pulmonary mucosal secretions. Third, the ability of IgA antibody to neutralize virus within mucosal epithelial cells in a polarized tissue culture system will be assessed. Information generated from these experiments should aide in the development of more effective strategies for immunization against common human respiratory viral pathogens.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08HL002002-01
Application #
3082429
Study Section
(SRC)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lamm, M E; Mazaneca, M B; Nedrud, J G et al. (1995) New functions for mucosal IgA. Adv Exp Med Biol 371A:647-50
Sokhandan, M; McFadden Jr, E R; Huang, Y T et al. (1995) The contribution of respiratory viruses to severe exacerbations of asthma in adults. Chest 107:1570-4
Mazanec, M B; Nedrud, J G; Kaetzel, C S et al. (1993) A three-tiered view of the role of IgA in mucosal defense. Immunol Today 14:430-5
Mazanec, M B; Lamm, M E; Lyn, D et al. (1992) Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res 23:1-12
Mazanec, M B; Kaetzel, C S; Lamm, M E et al. (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 89:6901-5
Stevenson, L W; Brunken, R C; Belil, D et al. (1990) Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 15:174-80
Luu, M; Stevenson, L W; Brunken, R C et al. (1990) Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J 119:668-70
Mazanec, M B; Nedrud, J G; Liang, X P et al. (1989) Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. J Immunol 142:4275-81